| Ytd | 64.39% | |
| 1y | 49.00% |
| Open | 4.41 | Prev Close | 4.46 | Low | 4.35 | High | 4.64 | Mkt Cap | 77.09M |
| Vol | 385.57K | Avg Vol | 1.19M | EPS | -0.37 | P/E | -12.05 | Forward P/E | -1.12 |
| Beta | 2.19 | Short Ratio | 4.80 | Inst. Own | 6.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 3.86 | 200-d Avg | 2.77 | 1yr Est | 31.67 |
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx" or the "Company") today issued the fo
WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx”
First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S
First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S
SAN DIEGO--(BUSINESS WIRE)--Kadima Neuropsychiatry Institute and its founder, Dr. David Feifel, have
SARASOTA, Fla, and BOSTON, June 23, 2026 /PRNewswire/ -- ZETA SURGICAL and HOPE Therapeutics, an NRx
D-Cycloserine (DCS) has been reported to augment the effect of Transcranial Magnetic Stimulation (TM
WILMINGTON, Del., June 22, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biop
MIAMI, June 05, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq:NRXP, “the Company”) announces
Offering was led by B Group Capital with significant participation from, among others, Columbia Thre
WILMINGTON, Del., June 03, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx P
Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100
WILMINGTON, Del., June 02, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx P
EMOCARE is a smartphone-based passive monitoring tool that generates a continuous, real-time measure
Deployment at HOPE's West Palm Beach clinic brings AI-powered, sub-millimetric image guidance to the
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, se
NRx Pharmaceuticals (NRXP) is downgraded from 'Buy' to 'Sell' following failures in ZYESAMI and NRX-
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
NRx Pharmaceuticals NASDAQ: NRXP said it advanced several regulatory, manufacturing and clinical ini
Key highlights from the first quarter of operations under the expanded management team include the f
NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.04 per share versus the Zacks
NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, w
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) will release earnings for its first quarter before the openi
WILMINGTON, Del., May 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Ph
The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism ar
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.
On Wednesday, 807 companies reached new 52-week lows.
Tuesday's session saw 211 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
US stocks recorded gains on the final trading day of January, with the Nasdaq Composite surging more
Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Frida
Gainers